These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 32720598)

  • 1.
    Li M; Sagastume EA; Lee D; McAlister D; DeGraffenreid AJ; Olewine KR; Graves S; Copping R; Mirzadeh S; Zimmerman BE; Larsen RH; Johnson FL; Schultz MK
    Curr Med Chem; 2020; 27(41):7003-7031. PubMed ID: 32720598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated cassette-based production of high specific activity [
    Li M; Zhang X; Quinn TP; Lee D; Liu D; Kunkel F; Zimmerman BE; McAlister D; Olewein K; Menda Y; Mirzadeh S; Copping R; Johnson FL; Schultz MK
    Appl Radiat Isot; 2017 Sep; 127():52-60. PubMed ID: 28521118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural modifications toward improved lead-203/lead-212 peptide-based image-guided alpha-particle radiopharmaceutical therapies for neuroendocrine tumors.
    Lee D; Li M; Liu D; Baumhover NJ; Sagastume EA; Marks BM; Rastogi P; Pigge FC; Menda Y; Johnson FL; Schultz MK
    Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1147-1162. PubMed ID: 37955792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Evaluation of
    Banerjee SR; Minn I; Kumar V; Josefsson A; Lisok A; Brummet M; Chen J; Kiess AP; Baidoo K; Brayton C; Mease RC; Brechbiel M; Sgouros G; Hobbs RF; Pomper MG
    J Nucl Med; 2020 Jan; 61(1):80-88. PubMed ID: 31253744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological effect of lead-212 localized in the nucleus of mammalian cells: role of recoil energy in the radiotoxicity of internal alpha-particle emitters.
    Azure MT; Archer RD; Sastry KS; Rao DV; Howell RW
    Radiat Res; 1994 Nov; 140(2):276-83. PubMed ID: 7938477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards translation of 212Pb as a clinical therapeutic; getting the lead in!
    Yong K; Brechbiel MW
    Dalton Trans; 2011 Jun; 40(23):6068-76. PubMed ID: 21380408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ Generated
    Stenberg VY; Juzeniene A; Bruland ØS; Larsen RH
    Curr Radiopharm; 2020; 13(2):130-141. PubMed ID: 32389119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma.
    Bolcaen J; Kleynhans J; Nair S; Verhoeven J; Goethals I; Sathekge M; Vandevoorde C; Ebenhan T
    Theranostics; 2021; 11(16):7911-7947. PubMed ID: 34335972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
    Lee D; Li M; Bednarz B; Schultz MK
    Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radionuclide spatial distribution and dose deposition for in vitro assessments of
    Frelin-Labalme AM; Roger T; Falzone N; Quan Lee B; Sibson NR; Vallis KA; Bernaudin M; Valable S; Corroyer-Dulmont A
    Med Phys; 2020 Mar; 47(3):1317-1326. PubMed ID: 31838744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted radionuclide therapy: frontiers in theranostics.
    Gallivanone F; Valente M; Savi A; Canevari C; Castiglioni I
    Front Biosci (Landmark Ed); 2017 Jun; 22(10):1750-1759. PubMed ID: 28410143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and dosimetry of
    Dos Santos JC; Schäfer M; Bauder-Wüst U; Lehnert W; Leotta K; Morgenstern A; Kopka K; Haberkorn U; Mier W; Kratochwil C
    Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1081-1091. PubMed ID: 30603987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved generator for the production of 212Pb and 212Bi from 224Ra.
    Atcher RW; Friedman AM; Hines JJ
    Int J Rad Appl Instrum A; 1988; 39(4):283-6. PubMed ID: 2838433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
    Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
    Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-tumor radionuclide therapy dosimetry: new paradigms in view of tumor microenvironment and angiogenesis.
    Zhu X; Palmer MR; Makrigiorgos GM; Kassis AI
    Med Phys; 2010 Jun; 37(6):2974-84. PubMed ID: 20632610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted alpha therapy: part I.
    Elgqvist J
    Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of short-lived high-LET alpha-emitting radionuclides lead-212 and bismuth-212 to low-LET X-rays on ovarian carcinoma.
    Rotmensch J; Atcher RW; Hines J; Toohill M; Herbst AL
    Gynecol Oncol; 1989 Dec; 35(3):297-300. PubMed ID: 2599463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha Particle-Emitting Radiopharmaceuticals as Cancer Therapy: Biological Basis, Current Status, and Future Outlook for Therapeutics Discovery.
    Coll RP; Bright SJ; Martinus DKJ; Georgiou DK; Sawakuchi GO; Manning HC
    Mol Imaging Biol; 2023 Dec; 25(6):991-1019. PubMed ID: 37845582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairs.
    Miller C; Rousseau J; Ramogida CF; Celler A; Rahmim A; Uribe CF
    Theranostics; 2022; 12(1):232-259. PubMed ID: 34987643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetry of [
    Orcutt KD; Henry KE; Habjan C; Palmer K; Heimann J; Cupido JM; Gottumukkala V; Cissell DD; Lyon MC; Hussein AI; Liu D; Li M; Johnson FL; Schultz MK
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.